Barclays PLC Has $328,000 Stock Holdings in Rapport Therapeutics (NASDAQ:RAPP)
Barclays PLC boosted its stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 43.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 18,497 shares of the company’s stock after acquiring an additional 5,634 shares during the quarter. Barclays PLC’s holdings in Rapport Therapeutics were worth $328,000 at the end of the most recent […]
Barclays PLC boosted its stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 43.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 18,497 shares of the company’s stock after acquiring an additional 5,634 shares during the quarter. Barclays PLC’s holdings in Rapport Therapeutics were worth $328,000 at the end of the most recent […]
